Correlation Engine 2.0
Clear Search sequence regions


  • AMPK (1)
  • factors (2)
  • heme (1)
  • humans (1)
  • isoforms (1)
  • lipids (2)
  • Nrf2 (1)
  • nuclear factor- kappa b (4)
  • PGC 1α (1)
  • ppar alpha (2)
  • ppar gamma (2)
  • ppar δ (1)
  • PPARs (7)
  • signal (1)
  • Sizes of these terms reflect their relevance to your search.

    Cardiotoxicity can be a complication of both drugs and a variety of other chemicals that affects morbidity, quality of life, and even mortality. The accumulation of lipids and inflammation have been implicated in the development of cardiotoxicity. The peroxisome proliferator-activated receptors (PPARs), a family of transcription factors, have a role in controlling the cardiac expression of genes involved in lipid and glucose metabolism and the inflammatory response. The different PPAR isoforms, PPARα, PPARγ, and PPARβ/δ, have a role in multiple functions in cardiac tissue. The protective nature of several naturally occurring chemicals (NCs) against cardiotoxicity by targeting PPARα and PPARγ has been reported. The literature related to the ability of several NCs to modulate cardiotoxicity through targeting the AMP-activated protein kinase (AMPK)/the PPARγ coactivator-1 alpha (PGC-1α)/PPARα, the PPARα/the nuclear factor-kappa B (NF-κB), and the PPARγ/the nuclear factor-erythroid 2 related factors 2 (Nrf2)/the heme oxygenase-1 (HO-1)/NF-κB signaling pathways are reviewed. © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

    Citation

    Fatemeh Yarmohammadi, A Wallace Hayes, Gholamreza Karimi. Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds. Cardiovascular toxicology. 2022 Apr;22(4):281-291

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35067839

    View Full Text